Press Release - Launch of Bosutinib Tablets 400mg.
Copies of newspaper publication
Intimation of analyst meet
Allotment of Employee Stock Options
Intimation of Analyst/Investor meet
Intimation of Analyst/Investor meet
Dr. Reddy's Laboratories Limited has informed the Exchange that the Annual Report in Form 20F for the fiscal year ended March 31, 2026 has been filed with United States Securities and Exchange Commission
Annual Secretarial Compliance certificate for the year ended March 31, 2026
Disclosure under Regulation 30 of SEBI (LODR) 2015, regarding Press release viz. "Dr. Reddy's Laboratories to Ring the Closing Bell at New York Stock Exchange."
Copies of newspaper publication
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 5,437.30 | 4,838.70 | 4,103.00 | 5,104.80 | 5,841.20 | 6,696.30 | 5,015.00 | 5,562.90 | 7,809.50 | 4,618.60 | 4,282.70 | 3,822.00 |
| YOY Revenue Growth % | 49.76% | -0.85% | 5.27% | 12.09% | 7.43% | 38.39% | 22.23% | 8.97% | 33.7% | -31.03% | -14.6% | -31.29% |
| Other Income | 233.60 | 223.10 | 227.60 | 212.70 | 217.80 | 207.60 | 235.40 | 414.40 | 398.30 | 364.20 | 360.30 | 567.20 |
| Total Income | 5,670.90 | 5,061.80 | 4,330.60 | 5,317.50 | 6,059.00 | 6,903.90 | 5,250.40 | 5,977.30 | 8,207.80 | 4,982.80 | 4,643.00 | 4,389.20 |
| Total Expenses + | 3,451.30 | 3,461.20 | 3,698.70 | 3,978.30 | 4,145.10 | 4,263.10 | 4,131.00 | 4,415.50 | 4,271.50 | 4,466.50 | 4,538.80 | 4,694.70 |
| Cost of Materials Consumed | 813.90 | 751.20 | 818.70 | 907.70 | 911.10 | 934.30 | 1,011.70 | 942.60 | 1,135.50 | 1,009.00 | 1,066.80 | 1,121.20 |
| Employee Benefit Expense | 740.20 | 783.70 | 782.30 | 779.50 | 855.90 | 840.10 | 794.40 | 797.10 | 887.30 | 867.90 | 960.20 | 834.50 |
| Other Expenses | 1,287.60 | 1,280.90 | 1,353.90 | 1,544.70 | 1,507.00 | 1,636.80 | 1,545.10 | 1,763.30 | 1,498.80 | 1,539.90 | 1,518.40 | 1,771.00 |
| Operating Profit | 1,986.00 | 1,377.50 | 404.30 | 1,126.50 | 1,696.10 | 2,433.20 | 884.00 | 1,147.40 | 3,538.00 | 152.10 | -256.10 | -872.70 |
| OPM % | 36.5% | 28.5% | 9.9% | 22.1% | 29% | 36.3% | 17.6% | 20.6% | 45.3% | 3.3% | -6% | -22.8% |
| Profit Before Tax + | 2,219.60 | 1,600.60 | 631.90 | 1,339.20 | 1,913.90 | 2,640.80 | 1,119.40 | 1,561.80 | 3,936.30 | 516.30 | 104.20 | -305.50 |
| Tax Expense | 580.20 | 408.00 | 156.70 | 304.40 | 496.70 | 758.70 | 270.00 | 361.10 | 975.10 | 129.00 | 13.60 | -86.10 |
| Tax % | 26.1% | 25.5% | 24.8% | 22.7% | 26% | 28.7% | 24.1% | 23.1% | 24.8% | 25% | 13.1% | - |
| Profit After Tax | 1,639.40 | 1,192.60 | 475.20 | 1,034.80 | 1,417.20 | 1,882.10 | 849.40 | 1,200.70 | 2,961.20 | 387.30 | 90.60 | -219.40 |
| EPS (Basic) | 98.66 | 71.68 | 28.55 | 62.14 | 85.10 | 22.60 | 10.20 | 14.41 | 35.59 | 4.65 | 1.09 | -2.63 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | 20,532.80 | 23,115.40 | 19,483.80 | 16,962.50 | 14,405.20 | 13,349.10 | 11,850.40 |
| YOY Revenue Growth % | -11.17% | 18.64% | 14.86% | 17.75% | 7.91% | 12.65% | - |
| Other Income | 1,689.60 | 1,003.40 | 862.30 | 591.30 | 482.00 | 801.10 | 743.20 |
| Total Income | 22,222.40 | 24,118.80 | 20,346.10 | 17,553.80 | 14,887.20 | 14,150.20 | 12,593.60 |
| Total Expenses + | 17,971.10 | 16,882.90 | 14,554.80 | 13,687.80 | 12,663.40 | 11,094.00 | 7,963.50 |
| Cost of Materials Consumed | 4,332.50 | 3,799.70 | 3,291.50 | 3,161.40 | 3,378.40 | 3,266.30 | 2,556.50 |
| Employee Benefit Expense | 3,549.90 | 3,287.50 | 3,085.70 | 2,832.60 | 2,434.60 | 2,270.10 | 2,030.20 |
| Other Expenses | 6,327.70 | 6,380.40 | 5,432.40 | 4,844.90 | 4,330.60 | 3,819.20 | 3,376.80 |
| Operating Profit | 2,561.70 | 6,232.50 | 4,929.00 | 3,274.70 | 1,741.80 | 2,255.10 | 3,886.90 |
| OPM % | 12.5% | 27% | 25.3% | 19.3% | 12.1% | 16.9% | 32.8% |
| Profit Before Exceptional | 4,251.30 | 7,235.90 | 5,791.30 | 3,866.00 | 2,223.80 | 3,056.20 | 2,775.80 |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit Before Tax + | 4,251.30 | 7,235.90 | 5,791.30 | 3,866.00 | 2,223.80 | 3,056.20 | 2,775.80 |
| Tax Expense | 1,031.60 | 1,886.50 | 1,449.30 | 1,253.20 | 600.60 | 869.80 | -161.90 |
| Tax % | 24.3% | 26.1% | 25% | 32.4% | 27% | 28.5% | -5.8% |
| Profit After Tax | 3,219.70 | 5,349.40 | 4,342.00 | 2,612.80 | 1,623.20 | 2,186.40 | 2,937.70 |
| EPS (Basic) | 38.68 | 64.22 | 260.95 | 157.37 | 97.85 | 131.84 | 177.23 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Non-Current Assets + | 25,078.90 | 21,787.90 | 12,543.40 | 11,331.90 | 10,700.50 | 10,470.30 | 0.00 |
| Property, Plant & Equipment | 7,752.70 | 5,865.40 | 5,109.40 | 4,737.90 | 4,024.00 | 3,579.20 | 0.00 |
| Capital Work in Progress | 1,369.10 | 2,156.40 | 1,171.90 | 899.10 | 1,186.40 | 877.10 | 0.00 |
| Non-Current Investments | 12,361.30 | 10,310.50 | 3,202.70 | 3,142.20 | 3,024.30 | 3,392.20 | 0.00 |
| Goodwill | 85.30 | 85.30 | 85.30 | 85.30 | 85.30 | 85.30 | 0.00 |
| Other Intangible Assets | 2,892.10 | 2,281.70 | 2,394.40 | 2,383.50 | 2,041.20 | 2,179.80 | 0.00 |
| Current Assets + | 18,523.20 | 16,503.00 | 17,815.90 | 14,042.90 | 13,792.50 | 11,159.30 | 0.00 |
| Inventories | 4,955.60 | 4,575.80 | 4,018.90 | 3,043.00 | 3,347.80 | 2,819.70 | 0.00 |
| Trade Receivables | 4,118.60 | 5,959.00 | 4,623.90 | 4,288.90 | 4,945.40 | 4,080.00 | 0.00 |
| Cash and Cash Equivalents | 337.50 | 319.70 | 201.40 | 112.30 | 1,159.50 | 1,306.30 | 0.00 |
| Current Investments | 1,000.00 | 1,000.00 | 1,000.00 | 1,000.00 | 1,000.00 | 1,000.00 | 0.00 |
| LIABILITIES & EQUITY | |||||||
| Total Equity | 31,365.60 | 28,856.60 | 24,240.80 | 20,474.20 | 18,336.20 | 16,983.70 | 0.00 |
| Equity Share Capital | 83.50 | 83.40 | 83.40 | 83.30 | 83.20 | 83.20 | 0.00 |
| Other Equity | 31,282.10 | 28,773.20 | 24,157.40 | 20,390.90 | 18,253.00 | 16,900.50 | 0.00 |
| Non-Current Liabilities | 1,094.00 | 782.50 | 580.40 | 460.90 | 114.30 | 85.60 | 0.00 |
| Current Liabilities | 11,142.50 | 8,651.80 | 5,538.10 | 4,439.70 | 6,045.10 | 4,560.30 | 0.00 |
| Total Liabilities | 12,236.50 | 9,434.30 | 6,118.50 | 4,900.60 | 6,159.40 | 4,645.90 | 0.00 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activities | 4,660.50 | 4,225.00 | 3,449.70 | 5,052.80 | 1,338.70 | 0.00 | 0.00 |
| Cash from Investing Activities | -5,784.70 | -5,697.60 | -3,430.30 | -3,447.60 | -2,038.00 | 0.00 | 0.00 |
| Cash from Financing Activities | 1,116.80 | 1,590.70 | 68.10 | -2,696.90 | 505.50 | 0.00 | 0.00 |
| Net Increase/Decrease in Cash | 17.80 | 118.30 | 89.10 | -1,047.20 | -145.90 | 0.00 | 0.00 |